Form 4: Accelerate Diagnostics CFO David Patience Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Accelerate Diagnostics, David Patience, reports the acquisition and disposal of company stock and restricted stock units on April 1, 2025.
Summary
- On April 1, 2025, David Patience, the CFO of Accelerate Diagnostics, engaged in transactions involving the company's stock.
- Patience acquired 20,000 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
- Simultaneously, Patience sold 6,816 shares of common stock at $0.71 per share to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Patience directly owns 64,568 shares of common stock and indirectly owns 760 shares through a spouse's IRA.
- Patience also holds 30,000 derivative securities in the form of Employee Restricted Stock Units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports required insider trading activity related to compensation.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider trading activity related to compensation.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Reporting person was granted a total of 50,000 RSUs, of which 40% vest on April 1, 2025 and the remaining 60% vest on April 1, 2026. |
| 04/01/2025 | Date of stock transactions: acquisition of 20,000 shares via RSU vesting and sale of 6,816 shares for tax obligations. |
| 04/02/2025 | Date of signature for the Form 4 filing. |
| 04/01/2026 | Remaining 60% of the 50,000 RSUs vest. |
Keywords
Accelerate Diagnostics, AXDX, David Patience, CFO, Form 4, Stock Transactions, Restricted Stock Units, RSU, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.